Conference Chair
Norio Nakatsuji Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University |
 Keynote Speakers
Takahiro Ochiya Professor, Tokyo Medical University | 
Kinichi Nakashima Professor, Department of Stem Cell Biology and Medicine, Kyushu University | 
Hiroshi Kawamoto Professor, Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University | 
Keiya Ozawa Professor Emeritus and Visiting Professor of the Division of Immuno-Gene & Cell Therapy, Jichi Medical University | 
Shoji Takeuchi Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo | 
Noboru Yamaji President, Chief Intelligence and Liaison Officer, Universal Cells, Inc., An Astellas Company |
|

Yuji Shiba Professor, Department of Regenerative Science and Medicine, Shinshu University | 
Chae-Ok Yun Professor, Department of Bioengineering, Hanyang University | 
Masafumi Onodera Head, Department of Human Genetics, National Center for Child Health and Development | 
Ross Macdonald Chief Executive Officer and Managing Director, Cynata Therapeutics Ltd |
OverviewSelectBIO is pleased to welcome you to the Second Annual Cell & Gene Therapy Asia 2019 which will be held in Kobe, Japan on November 11-12, 2019. This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application and technologies for gene therapy. The conference addresses the whole ecosystem of Cell & Gene Therapy and 3D-Bioprinting with a focus on 3D-Culture, Organoids, Bioprinting and Technology Platforms being developed to bring cell therapy, gene therapy and regenerative medicine to the clinic. In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan. With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Cell & Gene Therapy Asia 2019. SelectBIO is honored that Professor Norio Nakatsuji, Professor Emeritus Kyoto University will be leading the conference as Chairman and invites young scientists to submit poster abstracts to the conference and participate in the conference.
Information and Local Registration Facilities for this Conference are Also Available In: Japanese
|
Korean
|
Chinese (Simplified)
|
Chinese (Traditional)
Agenda Topics- 3D-Bioprinting and Tissue Engineering
- 3D-Culture and Organoids
- Clinical Trials and Commercialization of Cell Therapies
- Gene Therapy into the Clinic
- Clinical Pipeline
- Regulatory Landscape
- Technology Platforms
- iPSC-derived Cells for Toxicity Testing, Screening and Cellular Therapy
- Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
- Regenerative Medicine
- Stem Cells for Cellular Therapy
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateToshiyoshi Fujiwara, Professor & Chairman, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Brian Ikeda, Sales Director, Allevi Yasufumi Kaneda, Professor and Vice-President/Provost, Osaka University Thai-Yen Ling, Associate Professor, National Taiwan University Eugen Molodysky, Clinical Associate Professor, Sydney Medical School, University of Sydney Ryuichi Morishita, Professor of Clinical Gene Therapy, Osaka University School of Medicine Asuka Morizane, Assistant Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University Shin-ichi Muramatsu , Professor of Neurology, Jichi Medical University (JMU) Toshihiro Nakajima, Senior Technical Executive and General Manager of Manufacturing, GenomIdea, Inc. Yasutomo Nasu, Professor, Okayama University Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University Jun Takahashi, Professor, Kyoto University Ling-Mei Wang, President and COO, Steminent Biotherapeutics William G Whitford, Life Science Strategic Solutions Leader, DPS Group Haruka Yoshie, Application Specialist, CELLINK
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|